Search research articles
Contact Us
Filters
Showing results (401-410 of 817) with videos related to
Page
of 82
Sort By:
HIV Clinical Trials
|
October 9, 2001
Progression to AIDS or death as endpoints in HIV clinical trials
F Raffi, G Chêne, R Lassalle, et al.
Clinical Cardiology
|
January 25, 2018
Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200-499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study
Matthew Budoff, J Brent Muhlestein, Viet T Le, et al.
Journal of the American College of Cardiology
|
April 18, 2009
Depression after coronary artery disease is associated with heart failure
Heidi T May, Benjamin D Horne, John F Carlquist, et al.
Purinergic Signalling
|
November 16, 2022
Publisher Correction to: Adenosine receptor signalling in Alzheimer's disease
Phuc N H Trinh, Jo-Anne Baltos, Shane D Hellyer, et al.
The Journal of Biological Chemistry
|
September 25, 1992
High levels of "complexed" interleukin-6 in human blood
L T May, H Viguet, J S Kenney, et al.
Infection Control and Hospital Epidemiology
|
September 23, 2000
Occupational exposure to blood: search for a relation between personality and behavior
C Rabaud, A Zanea, J M Mur, et al.
Annals of the New York Academy of Sciences
|
January 1, 1989
Regulation of expression of interleukin-6. Molecular and clinical studies
A Ray, S B Tatter, U Santhanam, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 12, 2003
Polar auxin transport in the wood-forming tissues of hybrid aspen is under simultaneous control of developmental and environmental signals
J Schrader, K Baba, S T May, et al.
Journal of Intellectual Disability Research : JIDR
|
March 15, 2021
Effects of classroom-based active breaks on cognition, sitting and on-task behaviour in children with intellectual disability: a pilot study
E Mazzoli, J Salmon, C Pesce, et al.
Cardiology and Therapy
|
March 11, 2019
Effects of Evolocumab on the ApoA1 Remnant Ratio: A Pooled Analysis of Phase 3 Studies
Heidi T May, Joseph B Muhlestein, Yuhui Ma, et al.
Page
of 82
Search research articles
Search
Showing results (401-410 of 817) with videos related to
Sort By:
Page
of 82
HIV Clinical Trials
|
October 9, 2001
Progression to AIDS or death as endpoints in HIV clinical trials
F Raffi, G Chêne, R Lassalle, et al.
Clinical Cardiology
|
January 25, 2018
Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200-499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study
Matthew Budoff, J Brent Muhlestein, Viet T Le, et al.
Journal of the American College of Cardiology
|
April 18, 2009
Depression after coronary artery disease is associated with heart failure
Heidi T May, Benjamin D Horne, John F Carlquist, et al.
Purinergic Signalling
|
November 16, 2022
Publisher Correction to: Adenosine receptor signalling in Alzheimer's disease
Phuc N H Trinh, Jo-Anne Baltos, Shane D Hellyer, et al.
The Journal of Biological Chemistry
|
September 25, 1992
High levels of "complexed" interleukin-6 in human blood
L T May, H Viguet, J S Kenney, et al.
Infection Control and Hospital Epidemiology
|
September 23, 2000
Occupational exposure to blood: search for a relation between personality and behavior
C Rabaud, A Zanea, J M Mur, et al.
Annals of the New York Academy of Sciences
|
January 1, 1989
Regulation of expression of interleukin-6. Molecular and clinical studies
A Ray, S B Tatter, U Santhanam, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 12, 2003
Polar auxin transport in the wood-forming tissues of hybrid aspen is under simultaneous control of developmental and environmental signals
J Schrader, K Baba, S T May, et al.
Journal of Intellectual Disability Research : JIDR
|
March 15, 2021
Effects of classroom-based active breaks on cognition, sitting and on-task behaviour in children with intellectual disability: a pilot study
E Mazzoli, J Salmon, C Pesce, et al.
Cardiology and Therapy
|
March 11, 2019
Effects of Evolocumab on the ApoA1 Remnant Ratio: A Pooled Analysis of Phase 3 Studies
Heidi T May, Joseph B Muhlestein, Yuhui Ma, et al.
Page
of 82